Geiselmann B, Linden M, Sachs-Ericsson N
Forschungsgruppe Ambulante Therapie an der Psychiatrischen Klinik und Poliklinik der Freien Universität Berlin.
Eur Arch Psychiatry Neurol Sci. 1989;239(3):180-7. doi: 10.1007/BF01739652.
In an investigation of benzodiazepine (BDZ) prescription patterns, psychiatrists in private practice were found to exhibit "therapist non-compliance" with regard to general medical recommendations for BDZ use. The findings indicate that BDZ prescriptions in general (53% among patients treated with psychotropics) as well as long-term treatment of patients (37%) are quite common among private practice psychiatrists. BDZ treatment is not restricted to "minor psychiatric disorders", and contrary to the guidelines, even patients with substance dependence are not excluded. A positive association was found for BDZ use and patients' self-reported symptoms and health complaints, the number of other medications prescribed and age. In a discussion of therapist non-compliance it is proposed that this may be a consequence of a symptom-based treatment model, individual health concepts, the doctor-patient relationship and physician's cost-benefit analysis. Thus, psychiatrists' non-compliance may reflect to some extent a case-oriented treatment rationale.
在一项关于苯二氮䓬(BDZ)处方模式的调查中,发现私人执业的精神科医生在BDZ使用的一般医学建议方面表现出“治疗师不依从”。研究结果表明,一般情况下BDZ处方(在接受精神药物治疗的患者中占53%)以及患者的长期治疗(37%)在私人执业精神科医生中相当普遍。BDZ治疗并不局限于“轻度精神障碍”,与指南相反,甚至物质依赖患者也未被排除。研究发现BDZ的使用与患者自我报告的症状和健康投诉、所开其他药物的数量以及年龄呈正相关。在对治疗师不依从的讨论中,有人提出这可能是基于症状的治疗模式、个人健康观念、医患关系以及医生的成本效益分析的结果。因此,精神科医生的不依从可能在一定程度上反映了一种以病例为导向的治疗理念。